Welcome to LookChem.com Sign In|Join Free

Hubei Vanz Pharm Co.,Ltd

Diamond Supplier Enterprise Certification

Diamond
Supplier
5th
years
Home>>Products>>Veliparib Dihydrochloride Abt-888 cas 912445-05-7

Product Certification&
Enterprise Certification

More Detail

Hubei Vanz Pharm Co.,Ltd

Country: China (Mainland)

Business Type:Trading Company

Ms.Chelsea gao

Tel: 86-27-84492310

Ms.Bella Li

Tel: 008618986076206

Ms.Chelsea Gao

Tel: +86 27 84492310

Ms.Wendy

Tel: WhatsApp +8615927784577

Ms.Mirriam

Tel: +8618071739296

Mobile:

Tel: 86-27-84492310

Fax: 86-27-84402310

URL: http://www.vanzpharm.com/en/index.html

Province/state: Hubei

City: JIAYU

Street: FANHU INDUSTRY PARK

MaxCard:


    x
  • Ms.Bella Li
  • Ms.Chelsea Gao
Contact Suppliers

Veliparib Dihydrochloride Abt-888 cas 912445-05-7

CAS NO.912445-05-7

  • Min.Order: 1 Kilogram
  • Payment Terms: L/C,T/T,MoneyGram
Contact Supplier

Product Details

Keywords

  • Veliparib
  • Veliparib Dihydrochloride powder
  • 99% Veliparib Dihydrochloride

Quick Details

  • ProName: Veliparib Dihydrochloride Abt-888 cas ...
  • CasNo: 912445-05-7
  • Molecular Formula: C15H22O5
  • Appearance: white
  • Application: Artemisia annua is used as antimalaria...
  • DeliveryTime: 7-10 days
  • PackAge: drum
  • Port: Shanghai/Wuhan
  • ProductionCapacity: 1000 Kilogram/Day
  • Purity: 99
  • Storage: room
  • LimitNum: 1 Kilogram

Superiority

Veliparib Dihydrochloride Abt-888 cas 912445-05-7 

Product Name:    Veliparib Dihydrochloride
 CAS: 912444-00-9
MF: C13H16N4O.2ClH
MW: 317.218

Details

Veliparib Dihydrochloride Abt-888 cas 912445-05-7 

Product Name:    Veliparib Dihydrochloride
 CAS: 912444-00-9
MF: C13H16N4O.2ClH
MW: 317.218 

Veliparib  is a potent PARP1 and PARP2 inhibitor with Ki of 5.2nM and 2.9nM, respectively, inhibiting SIRT2.Phase3.ABT-888 effectively inhibited PARP, and the Ki value of PARP-1 and PARP-2 was 5.2 nM and 2.9nM, respectively.ABT-888 decreased the survival rate of cloned genes in lung cancer H460 cells and inhibited DNA repair.ABT-888 inhibited C41 cells with an EC50 of 2nM.ABT-888 is used in combination with radiation to reduce tumor angiogenesis.